Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
BMC Musculoskeletal Disorders|February 20, 2021
Long-term outcomes of the modified Nirschl technique for lateral Epicondylitis: a retrospective studySoonchul Lee, In-Tae Hong, Soohyun Lee, et al.
Molecules (Basel, Switzerland)|January 21, 2022
The Effects of Selenium on Bone Health: From Element to TherapeuticsTaeyoung Yang, So-Young Lee, Kyung-Chae Park, et al.
Journal of Clinical Medicine|January 11, 2025
Examining the Relationship Between Sarcopenia and Rotator Cuff Tears: A Retrospective Comparative StudyJae-Hwa Kim, Inseok Jang, Simho Jeong, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 25, 2025
Serdemetan promotes bone regeneration via coordinated regulation of osteoblast and osteoclast activitySol Jeong, Seung-Chan An, Hyun-Ju An, et al.
Clinics in Orthopedic Surgery|June 7, 2021
Anatomic Repair of the Central Slip with Anchor Suture Augmentation for Treatment of Established Boutonniere DeformityJun-Ku Lee, Soonchul Lee, Minwook Kim, et al.
Patient Preference and Adherence|October 30, 2020
Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription PatternKyung Rae Ko, Sangcheol Lee, Seo Yoon Oh, et al.
Frontiers in Oncology|April 2, 2024
Corrigendum: miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancerSujin Choi, Soonchul Lee, Young-Hoon Han, et al.
International Journal of Pharmaceutics|April 9, 2025
Therapeutic potential of Polydopamine-Coated selenium nanoparticles in Osteoarthritis treatmentKyung-Chae Park, Junwon Choi, Sujin Choi, et al.
Frontiers in Oncology|September 5, 2022
miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancerSujin Choi, Soonchul Lee, Young-Hoon Han, et al.
Pageof 11